
CAS: 2749568-16-7
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | IDH2R140Q-IN-2 REF: 54-BUP08470CAS: 2749568-16-7 | ≥98% | 2,033.00 €~5,775.00 € | Tue 06 May 25 |
![]() | IDH2R140Q-IN-2 REF: TM-T79745CAS: 2749568-16-7 | 99.85% | 378.00 €~2,375.00 € | Mon 23 Jun 25 |

Ref: 54-BUP08470
25mg | 2,033.00 € | ||
50mg | 2,547.00 € | ||
100mg | 3,216.00 € | ||
200mg | 3,973.00 € | ||
500mg | 5,775.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025

IDH2R140Q-IN-2
CAS:2749568-16-7
IDH2R140Q-IN-2 is an IDH2R140Q inhibitor indicated for the study of acute myeloid leukaemia (AML).
Formula:
C21H18F6N6O
Purity:
99.85%
Color and Shape:
Solid
Molecular weight:
484.4
Ref: TM-T79745
1mg | 378.00 € | ||
5mg | 922.00 € | ||
10mg | 1,121.00 € | ||
25mg | 1,501.00 € | ||
50mg | 1,882.00 € | ||
100mg | 2,375.00 € |
Estimated delivery in United States, on Monday 23 Jun 2025